HCA Healthcare sees TD Cowen price cut, shares stay in S&P 500 focus

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 18:18.

HCA Healthcare (US40412C1018) stays in focus on the NYSE after TD Cowen cut its price target to 431 dollars from 500 dollars while maintaining a Buy rating, according to a MarketScreener summary published on June 22, 2026.MarketScreener note on the TD Cowen update The S&P 500 constituent most recently closed at 375.17 dollars on June 18, 2026, implying double-digit upside to the new target.

What TD Cowen changed

The TD Cowen adjustment, reported at 07:22 a.m. EDT on June 22, 2026, lowered the HCA Healthcare price target by 69 dollars to 431 dollars but kept the rating at Buy, signaling continued positive stance despite the target cut.MarketScreener note on the TD Cowen update The same MarketScreener overview lists an average analyst target price of 503.57 dollars for HCA, well above the current market level.

HCA Healthcare shares finished regular NYSE trading on June 18, 2026 at 375.17 dollars, down 3.35 percent on the day, leaving the stock about 19.64 percent lower year to date, according to the same data snapshot.MarketScreener price and performance data That level places the shares meaningfully below both TD Cowen’s revised 431 dollar target and the broader Street average of just over 500 dollars.

Consensus and recent earnings backdrop

Consensus data compiled by MarketScreener show HCA Healthcare with an average target price of 503.57 dollars, underscoring that TD Cowen’s new 431 dollar objective sits at the lower end of the target range while still implying upside from the latest close.MarketScreener note on the TD Cowen update The majority of brokers tracked by MarketScreener continue to rate the shares positively, although individual target trims reflect a more cautious stance after recent volatility.

First quarter 2026 results provide part of the backdrop for these adjustments. Tickeron highlights that HCA Healthcare generated revenue of 19.11 billion dollars and net income of 1.62 billion dollars in that period but missed market expectations, citing softer patient volumes linked to respiratory illnesses and weather disruptions, which triggered a stock drop of more than 8 percent on the day of the release.Tickeron comparison commentary on HCA and peer Ensign Group In that analysis, Tickeron notes that Ensign Group shows stronger recent trend consistency and lower volatility relative to HCA, underscoring competitive pressure within the U.S. hospital and post-acute care segment.

How HCA Healthcare makes its money

HCA Healthcare operates a large network of acute care hospitals and outpatient facilities across the United States, generating revenue primarily from patient services such as inpatient admissions, surgeries, emergency room visits and diagnostic procedures, as outlined in its corporate materials.HCA Healthcare corporate overview The group also derives income from physician services, ambulatory surgery centers and specialized programs in cardiology, oncology and obstetrics, with payer mixes spanning commercial insurers, Medicare, Medicaid and self-pay patients.

Where the HCA Healthcare shares trade today

HCA Healthcare shares (US40412C1018) most recently traded on the NYSE at 375.17 dollars as of 2026-06-18, 16:00 Eastern Time.

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. All data and assessments are based on sources believed to be reliable as of the stated dates but cannot be guaranteed.